Physician profile
Monica Joyner
NPI 1568608321
$521.83
in general payments reported to CMS, 2019-2025
10 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.22 · 2020: $15.04 · 2021: $85.78 · 2022: $74.44 · 2023: $78.56 · 2024: $30.60 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $270.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $153.87 | 2019-2023 | V.A.C. Dermatac, Activ.A.C., V.A.C. Veraflo |
| Solventum Corporation | $111.49 | 2025 | V.A.C. Veraflo Cleanse Choice |
| Smith+Nephew, INC. | $110.01 | 2022-2025 | Collagenase Santyl, Renasys Touch, Allevyn Heel 10.5cm X 13.5cm Ctn 5 |
| Hollister Incorporated | $29.14 | 2019-2021 | |
| Tactile Systems Technology INC | $26.44 | 2019-2024 | Entre Plus, Flexitouch Plus |
| Integra Lifesciences Corporation | $20.79 | 2022 | |
| Insmed, INC. | $18.96 | 2019 | |
| Medela LLC | $18.78 | 2019 | |
| Coloplast Corp | $17.31 | 2025 | |
| Medline Industries Lp | $15.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Joyner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.